T5	Subject 22 47	18 other paediatric cases
T6	Effect 51 79	naphthylimidazoline exposure
T7	Treatment 51 70	naphthylimidazoline
T9	Population 22 24	18
T10	Sub-Disorder 31 41	paediatric
T11	Drug 51 70	naphthylimidazoline
T12	Route 71 79	exposure
